A-1 Ltd Q1 FY27: Consolidated PAT up 429% YoY to ₹3.16 Cr on order-led revenue surge

A-1 Limited (formerly A-1 Acid), a chemicals and sports-equipment trading company, reported consolidated revenue of ₹175.01 Cr for Q1 FY27 (quarter ended 30 June 2026), up ~171% YoY from ₹64.69 Cr and ~20% QoQ from ₹145.27 Cr. Consolidated PAT was ₹3.16 Cr, up ~429% YoY from ₹0.60 Cr but down ~27% QoQ from ₹4.36 Cr. There are no exceptional items in either the current or comparable periods, so both moves are on a reported, unadjusted basis — no raw-vs-adjusted split is needed here. Standalone and consolidated figures are effectively identical (PBT ₹4.30 Cr, PAT ₹3.16 Cr in both), since the Group's only associate, A-1 Sureja Industries, added just ₹1.07 Lakh for the quarter. Growth was concentrated in the Acids & Chemicals segment, which supplied ₹171.95 Cr of the ₹175.13 Cr in total segment revenue (~98%), against ₹6.48 Cr a year ago. This lines up with a ₹35 Cr chemical supply order win flagged on 12 June 2026 and the company's appointment as primary dealer for Ishan Dyes Chemicals on 30 June 2026, both landing inside the quarter. But this is a trading-led business — Purchase of Stock-in-Trade is ₹160.70 Cr of ₹170.83 Cr total standalone expenses (~94%) — so revenue growth did not scale the bottom line proportionately: net profit margin was 1.81%, up from a thin 0.92% a year ago but down from 3.00% last quarter, as finance costs more than doubled YoY (₹0.98 Cr vs ₹0.42 Cr) on the working capital needed to fund the larger volumes. There is no prior management guidance or concall commentary on record for this company, and a web search for street/analyst coverage of this quarter turned up nothing specific to A-1 Limited (BSE: 542012) — the stock appears to run without formal broker estimates, so both vsGuidance and vsStreet are unknown here. Separately, on 13 May 2026 the company twice revised its FY26 filings (once for an "integrated filing" error, once for a typo), though its FY26 audit report (16 May 2026) and this quarter's own limited-review report both carry unmodified opinions. EPS for the quarter was ₹0.07 (not annualised) on the enlarged post-bonus/post-split base of 46 Cr shares (following the December 2025 3:1 bonus issue and 10:1 face-value split), against ₹0.09 in Q4 FY26. The next quarter will show whether the ₹35 Cr order and new dealership are a one-time volume boost or a step-change in run-rate — the QoQ margin compression this quarter (3.00%→1.81%) suggests the incremental revenue is being won at thinner spreads, worth tracking against Q2 FY27 segment revenue and finance-cost trends.